A Quantum Union: Quanta, Inc & RST-Sanexas Announce Partnership

BURBANK, Calif., March 19, 2020 /PRNewswire/ -- Quanta, Inc. (QNTA: OTC) and Resonant Specific Technologies, Inc. announced a medical industry partnership today wherein Quanta will co-brand and supply its Muscle Rub to assist in reducing patient discomfort as an adjunct to treatment protocols that use RST-Sanexas neoGEN Electric Cell Signaling Treatment (EcST) devices in physician offices, clinics and hospitals to facilitate patient's pain management and discomfort.

For more than 30 years, Las Vegas-based RST Sanexas has been the leader in Electric Cell Signaling Technology – providing treatment systems and devices to clinics, physicians and hospitals for non-invasive, drug-free, pain-free rehabilitation options for patients. Its neoGEN-Series "state-of-the-art" medical device provides innovative, non-invasive relief from most all chronic pain conditions including pain from neuropathy.

Quanta is an applied science company based in Burbank using quantum mechanics to enhance ingredient efficacy at the sub-atomic level.

A Quantum Connection

Quanta's signature muscle rub derives its unique efficacy from the application of quantum mechanics to biological ingredients. In this case, arnica, and other ingredients are "frequency engineered" to deliver 500% bioavailability (acting as a COX-2 inhibitor). Similarly, RST Sanexas harnesses Quantum Resonance-Specific induction (QRSI™) to affect the electromagnetic field potentials between cells that appear to promote beneficial healing effects.

Both Quanta and RST Sanexas work at the sub-atomic level with the intention of creating beneficial biological change.

Quanta founder/CEO Eric Rice said, "Up to now, the notion of "quantum" was a theory – out of reach for the average person. Working with like-minded partners who share not only our values but our science, is our goal. This partnership is kismet for us and for the millions of patients we'll help treat together."

RST-Sanexas' science spokesman states, "Our technologies are naturally aligned, which powers our belief in Quanta's Muscle Rub as an ideal adjunctive therapeutic application for our patients.  Topical application at home as part of a self-care routine offers a high-quality experience and an ideal between-treatment regimens." 

Under the parameters of the partnership, Quanta will co-brand and supply a substantial first run of Muscle Rub product and potentially other products to RST Sanexas for distribution alongside its devices – representing a multimillion-dollar revenue stream for both. RST Sanexas produces and distributes its FDA-cleared devices to physicians, clinics, and others across the country. Thousands of RST-Sanexas neoGEN systems are currently in-service representing millions of patient treatments with another estimated 1,200 systems on track for delivery this year.

About Quanta: Quanta Technology and its revolutionary technology click here. 

About RST Sanexas: https://www.rstsanexas.com/company  

SOURCE Quanta, Inc.